195 related articles for article (PubMed ID: 16438098)
41. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
Stock C; Brenner H
Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
[TBL] [Abstract][Full Text] [Related]
42. A provider intervention to improve colorectal cancer screening in county health centers.
Lane DS; Messina CR; Cavanagh MF; Chen JJ
Med Care; 2008 Sep; 46(9 Suppl 1):S109-16. PubMed ID: 18725822
[TBL] [Abstract][Full Text] [Related]
43. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
[TBL] [Abstract][Full Text] [Related]
44. Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey.
Subramanian S; Amonkar MM; Hunt TL
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):409-16. PubMed ID: 15734966
[TBL] [Abstract][Full Text] [Related]
45. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
46. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
O'Malley AS; Forrest CB; Feng S; Mandelblatt J
Arch Intern Med; 2005 Oct; 165(18):2129-35. PubMed ID: 16217003
[TBL] [Abstract][Full Text] [Related]
47. Colorectal cancer screening in young patients with poor health and severe comorbidity.
Sultan S; Conway J; Edelman D; Dudley T; Provenzale D
Arch Intern Med; 2006 Nov; 166(20):2209-14. PubMed ID: 17101938
[TBL] [Abstract][Full Text] [Related]
48. Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.
Keller R; Schätzle A; Flieger D; Christl SU; Fischbach W
Z Gastroenterol; 2003 Jul; 41(7):655-8. PubMed ID: 12858236
[TBL] [Abstract][Full Text] [Related]
49. Measuring the quality of colorectal cancer screening: the importance of follow-up.
Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
[TBL] [Abstract][Full Text] [Related]
50. Trends in colorectal cancer screening with home-based fecal occult blood tests in adults ages 50 to 64 years, 2000-2008.
Bandi P; Cokkinides V; Smith RA; Jemal A
Cancer; 2012 Oct; 118(20):5092-9. PubMed ID: 22434529
[TBL] [Abstract][Full Text] [Related]
51. Predictors of fecal occult blood test (FOBT) completion among low-income adults.
Greiner KA; James AS; Born W; Hall S; Engelman KK; Okuyemi KS; Ahluwalia JS
Prev Med; 2005 Aug; 41(2):676-84. PubMed ID: 15917068
[TBL] [Abstract][Full Text] [Related]
52. Barriers to colorectal cancer screening: inadequate knowledge by physicians.
Gennarelli M; Jandorf L; Cromwell C; Valdimarsdottir H; Redd W; Itzkowitz S
Mt Sinai J Med; 2005 Jan; 72(1):36-44. PubMed ID: 15682261
[TBL] [Abstract][Full Text] [Related]
53. Validation of self-reported history of colorectal cancer screening.
Khoja S; McGregor SE; Hilsden RJ
Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
[TBL] [Abstract][Full Text] [Related]
54. Dually eligible and colorectal cancer screening: too little, too late?
Carcaise-Edinboro P; Bradley CJ; Dahman B
J Health Care Poor Underserved; 2009 Aug; 20(3):854-65. PubMed ID: 19648712
[TBL] [Abstract][Full Text] [Related]
55. Two-year trends in colorectal cancer screening after switch to a high-deductible health plan.
Wharam JF; Graves AJ; Landon BE; Zhang F; Soumerai SB; Ross-Degnan D
Med Care; 2011 Sep; 49(9):865-71. PubMed ID: 21577162
[TBL] [Abstract][Full Text] [Related]
56. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
57. Data sources for measuring colorectal endoscopy use among Medicare enrollees.
Schenck AP; Klabunde CN; Warren JL; Peacock S; Davis WW; Hawley ST; Pignone M; Ransohoff DF
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2118-27. PubMed ID: 17932360
[TBL] [Abstract][Full Text] [Related]
58. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
[TBL] [Abstract][Full Text] [Related]
59. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
60. Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.
Rossi F; Sosa JA; Aslanian HR
J Clin Gastroenterol; 2008; 42(10):1089-94. PubMed ID: 18936643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
